Cancer Pathology and Tumor Biomarkers

Cancer diagnostics is increasingly reliant on precision pathology, which leverages tumor biomarkers for diagnosis, prognosis, and therapy selection. Tumor heterogeneity, biomarker discovery, and immunopathology have become pivotal in guiding oncology decisions. The session will cover predictive and prognostic biomarkers, molecular subtyping, and the role of companion diagnostics in targeted therapies. Emphasis is placed on integrating histopathology, immunohistochemistry, and molecular profiling for comprehensive cancer evaluation. Insights into liquid biopsies, epigenetics, and resistance mechanisms are also included, offering a holistic view of the future of cancer diagnostics.

    Related Conference of Cancer Pathology and Tumor Biomarkers

    March 25-26, 2027

    25th European Pathology Congress

    Paris, France
    March 29-30, 2027

    25th Annual Pathology Congress

    Dubai, UAE

    Cancer Pathology and Tumor Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in